Israel to seek new security deal with the US, FT reports

Israel is preparing to seek a new 10-year security agreement with the U.S., prioritising joint military and defence projects over direct cash grants in upcoming talks with the Trump administration. The move signals a potential gradual reduction of the $3.3 billion a year in direct grant aid that Israel currently uses to buy U.S. weapons, within the context of the 2016 memorandum of understanding that provides $38 billion through September 2028 ($33 billion in equipment grants and $5 billion for missile defence). Prime Minister Netanyahu has said he hopes to ‘taper off’ dependence on U.S. military aid over the next decade, a shift that could affect procurement arrangements and defence-sector cooperation but is currently at the negotiation stage.

Analysis

Market structure will tilt toward integrated, high-margin prime contractors and Israeli system integrators that can capture co-development premiums. Winners: US primes (LMT, RTX, NOC) for long-duration joint programs and Elbit Systems (ESLT) for IP-rich subsystems; losers: low-margin component suppliers and any OEMs dependent on predictable $3.3bn/yr FMS-funded purchases. Pricing power shifts from pure hardware vendors to firms owning software/missile/air-defence IP, tightening margins at commodity suppliers within 6–36 months.

Tail risks include a sudden political rupture (US admin or Israeli budget shock) that could remove >50% of expected grant flows and widen Israel 10y CDS by 100–200bp in a stress scenario; military escalation could flip sentiment in days. Immediate (days): muted; short-term (weeks–months): negotiation outcomes and announcement cadence; long-term (3–10 years): structural rebalancing from grants to offsets and joint R&D, shifting capex and export patterns. Hidden dependency: Israeli exporters still rely on US components — thickening joint programs may repatriate IP but increase U.S. export-control frictions.

Trade implications: overweight established primes and Israeli integrators while hedging sovereign/FX exposure. Direct plays: 1–3% longs in LMT and NOC (12–24 months) to capture program awards; 1–2% long ESLT (6–12 months) to capture export upside if joint projects announced. Options: buy 9–12 month call spreads on LMT/ESLT (buy 20% ITM, sell 40% OTM) to limit premium; pair trade long ESLT vs short commodity component suppliers (e.g., unnamed small caps) where revenue is >30% Israel FMS-exposed.

Contrarian view: market assumes US primes uniformly win — but Israel’s push for joint ownership could boost Israeli-listed integrators and small-cap tech vendors more than large primes over 2–5 years. The reaction is underdone for ESLT (possible 15–30% upside if >$1bn in joint projects announced) and potentially overdone for commodity suppliers whose orderbooks could drop 20–40%. Monitor three catalysts: official US-Israel MOU language in next 60 days, Israeli budget revisions by Q2 2026, and Israel shekel moves ±3% as trade triggers.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Lockheed Martin (LMT) with a 12–24 month horizon; target 15–25% upside if joint-program awards >$2bn materialize. Trim if LMT underperforms S&P by >5% for 30 trading days.
• Initiate a 1–2% long position in Elbit Systems (ESLT) (Nasdaq) with a 6–12 month horizon; use a stop-loss at -18% and take-profit at +25% if Israeli joint-project announcements exceed $500m within 90 days.
• Buy 9–12 month call spreads on LMT and ESLT (size = 0.5–1% notional each): buy a call ~20% ITM and sell ~40% OTM to play program upside while capping premium. Close spreads if implied volatility rises >40% or if negotiation language removes grant reduction clause.
• Reduce direct exposure to small-cap Israeli suppliers / commodity defence subcontractors by 30% (reallocate to primes) if Israeli annual grants are formally cut by >20% in the next MOU; hedge Israel sovereign exposure by buying 1–2% notional of EIS put options or 5y CDS protection if available.